LivaNova PLC (LIVN)
USD 35.56
(-5.14%)
USD 35.56
(-5.14%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.15 Billion USD | 12.89% |
| 2022 | 1.02 Billion USD | -1.31% |
| 2021 | 1.03 Billion USD | 10.83% |
| 2020 | 934.2 Million USD | -13.84% |
| 2019 | 1.08 Billion USD | -2.06% |
| 2018 | 1.1 Billion USD | 9.35% |
| 2017 | 1.01 Billion USD | -16.61% |
| 2016 | 1.21 Billion USD | 316.35% |
| 2015 | 291.55 Million USD | 3.38% |
| 2014 | 282.01 Million USD | 10.89% |
| 2013 | 254.32 Million USD | 16.39% |
| 2012 | 218.5 Million USD | 14.72% |
| 2011 | 190.46 Million USD | 13.52% |
| 2010 | 167.77 Million USD | 16.83% |
| 2009 | 143.6 Million USD | 18.45% |
| 2008 | 121.22 Million USD | -7.44% |
| 2007 | 130.96 Million USD | 6.1% |
| 2006 | 123.44 Million USD | 19.33% |
| 2005 | 103.44 Million USD | -6.57% |
| 2004 | 110.72 Million USD | 5.99% |
| 2003 | 104.46 Million USD | 49.0% |
| 2002 | 70.11 Million USD | 0.0% |
| 2000 | 47.88 Million USD | 60.16% |
| 1999 | 29.9 Million USD | 100.67% |
| 1998 | 14.9 Million USD | 964.29% |
| 1997 | 1.4 Million USD | 0.0% |
| 1996 | 1.4 Million USD | 40.0% |
| 1995 | 1 Million USD | 150.0% |
| 1994 | 400 Thousand USD | 300.0% |
| 1993 | 100 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 294.91 Million USD | -4.9% |
| 2024 Q2 | 318.57 Million USD | 8.02% |
| 2024 Q3 | 318.12 Million USD | -0.14% |
| 2023 Q2 | 293.9 Million USD | 11.58% |
| 2023 Q3 | 286.1 Million USD | -2.65% |
| 2023 FY | 1.15 Billion USD | 12.89% |
| 2023 Q4 | 310.1 Million USD | 8.39% |
| 2023 Q1 | 263.4 Million USD | -4.18% |
| 2022 FY | 1.02 Billion USD | -1.31% |
| 2022 Q4 | 274.9 Million USD | 8.83% |
| 2022 Q3 | 252.6 Million USD | -0.63% |
| 2022 Q2 | 254.2 Million USD | 5.84% |
| 2022 Q1 | 240.17 Million USD | -11.08% |
| 2021 Q1 | 247.6 Million USD | -8.16% |
| 2021 Q2 | 264.48 Million USD | 6.82% |
| 2021 Q3 | 253.21 Million USD | -4.26% |
| 2021 Q4 | 270.1 Million USD | 6.67% |
| 2021 FY | 1.03 Billion USD | 10.83% |
| 2020 Q3 | 240.08 Million USD | 31.76% |
| 2020 FY | 934.2 Million USD | -13.84% |
| 2020 Q2 | 182.2 Million USD | -24.83% |
| 2020 Q1 | 242.4 Million USD | -15.72% |
| 2020 Q4 | 269.6 Million USD | 12.29% |
| 2019 Q1 | 250.8 Million USD | -15.56% |
| 2019 Q2 | 277.16 Million USD | 10.51% |
| 2019 Q4 | 287.6 Million USD | 7.07% |
| 2019 Q3 | 268.61 Million USD | -3.09% |
| 2019 FY | 1.08 Billion USD | -2.06% |
| 2018 Q1 | 250.4 Million USD | -10.06% |
| 2018 Q3 | 272.08 Million USD | -5.36% |
| 2018 Q4 | 297 Million USD | 9.16% |
| 2018 Q2 | 287.5 Million USD | 14.82% |
| 2018 FY | 1.1 Billion USD | 9.35% |
| 2017 Q4 | 278.4 Million USD | -10.1% |
| 2017 FY | 1.01 Billion USD | -16.61% |
| 2017 Q3 | 309.66 Million USD | -3.65% |
| 2017 Q2 | 321.38 Million USD | 12.73% |
| 2017 Q1 | 285.1 Million USD | -8.21% |
| 2016 Q4 | 310.6 Million USD | 5.19% |
| 2016 Q3 | 295.26 Million USD | -8.02% |
| 2016 FY | 1.21 Billion USD | 316.35% |
| 2016 Q2 | 321 Million USD | 11.85% |
| 2016 Q1 | 287 Million USD | 0.0% |
| 2015 Q3 | 67.52 Million USD | -16.65% |
| 2015 FY | 291.55 Million USD | 3.38% |
| 2015 Q2 | 81.01 Million USD | 9.37% |
| 2015 Q1 | 74.07 Million USD | 2.78% |
| 2014 Q1 | 74.84 Million USD | 9.76% |
| 2014 Q2 | 72 Million USD | -3.8% |
| 2014 Q4 | 72.06 Million USD | -1.84% |
| 2014 Q3 | 73.41 Million USD | 1.96% |
| 2014 FY | 282.01 Million USD | 10.89% |
| 2013 Q3 | 70.1 Million USD | 1.78% |
| 2013 Q4 | 68.19 Million USD | -2.72% |
| 2013 Q1 | 68.34 Million USD | 9.0% |
| 2013 FY | 254.32 Million USD | 16.39% |
| 2013 Q2 | 68.87 Million USD | 0.77% |
| 2012 Q3 | 62.95 Million USD | 4.37% |
| 2012 Q1 | 57.6 Million USD | 5.63% |
| 2012 FY | 218.5 Million USD | 14.72% |
| 2012 Q4 | 62.7 Million USD | -0.41% |
| 2012 Q2 | 60.32 Million USD | 4.71% |
| 2011 Q3 | 53.69 Million USD | 1.96% |
| 2011 FY | 190.46 Million USD | 13.52% |
| 2011 Q4 | 54.53 Million USD | 1.57% |
| 2011 Q2 | 52.66 Million USD | 3.01% |
| 2011 Q1 | 51.12 Million USD | 8.58% |
| 2010 Q2 | 44.79 Million USD | -6.15% |
| 2010 Q1 | 47.73 Million USD | 16.94% |
| 2010 FY | 167.77 Million USD | 16.83% |
| 2010 Q3 | 47.46 Million USD | 5.94% |
| 2010 Q4 | 47.08 Million USD | -0.8% |
| 2009 Q1 | 38.57 Million USD | 9.41% |
| 2009 Q4 | 40.82 Million USD | 0.25% |
| 2009 FY | 143.6 Million USD | 18.45% |
| 2009 Q3 | 40.71 Million USD | 5.76% |
| 2009 Q2 | 38.5 Million USD | -0.2% |
| 2008 FY | 121.22 Million USD | -7.44% |
| 2008 Q2 | 33.73 Million USD | -0.47% |
| 2008 Q4 | 35.25 Million USD | -2.14% |
| 2008 Q1 | 33.89 Million USD | 15.61% |
| 2008 Q3 | 36.03 Million USD | 6.82% |
| 2007 Q2 | 29.07 Million USD | -7.5% |
| 2007 Q1 | 31.43 Million USD | -0.73% |
| 2007 Q3 | 28.94 Million USD | -0.44% |
| 2007 Q4 | 29.31 Million USD | 1.28% |
| 2007 FY | 130.96 Million USD | 6.1% |
| 2006 Q1 | 36.04 Million USD | 15.15% |
| 2006 Q4 | 31.66 Million USD | -7.25% |
| 2006 Q3 | 34.14 Million USD | 1.21% |
| 2006 FY | 123.44 Million USD | 19.33% |
| 2006 Q2 | 33.73 Million USD | -6.43% |
| 2005 FY | 103.44 Million USD | -6.57% |
| 2005 Q4 | 31.3 Million USD | 7.68% |
| 2005 Q3 | 29.07 Million USD | 7.59% |
| 2005 Q2 | 27.01 Million USD | 1.35% |
| 2005 Q1 | 26.65 Million USD | 1.71% |
| 2004 Q1 | 26.3 Million USD | -7.48% |
| 2004 Q2 | 25.14 Million USD | -4.4% |
| 2004 Q3 | 25.42 Million USD | 1.08% |
| 2004 FY | 110.72 Million USD | 5.99% |
| 2004 Q4 | 26.21 Million USD | 3.11% |
| 2003 Q2 | 26.68 Million USD | -3.94% |
| 2003 Q4 | 28.43 Million USD | -2.94% |
| 2003 FY | 104.46 Million USD | 49.0% |
| 2003 Q1 | 27.77 Million USD | 0.78% |
| 2003 Q3 | 29.29 Million USD | 9.8% |
| 2002 Q3 | 26.07 Million USD | 13.08% |
| 2002 Q4 | 27.56 Million USD | 5.71% |
| 2002 FY | 70.11 Million USD | 0.0% |
| 2002 Q2 | 23.05 Million USD | 13.99% |
| 2002 Q1 | 20.22 Million USD | 9.99% |
| 2001 Q3 | 16.88 Million USD | 15.51% |
| 2001 Q2 | 14.61 Million USD | 2.03% |
| 2001 Q4 | 18.38 Million USD | 8.92% |
| 2001 Q1 | 14.32 Million USD | 0.86% |
| 2000 Q2 | 14.07 Million USD | 0.28% |
| 2000 Q1 | 14.03 Million USD | 26.44% |
| 2000 FY | 47.88 Million USD | 60.16% |
| 2000 Q4 | 14.2 Million USD | 6.35% |
| 2000 Q3 | 13.35 Million USD | -5.12% |
| 1999 Q2 | 9.9 Million USD | 22.22% |
| 1999 Q1 | 8.1 Million USD | 22.73% |
| 1999 Q3 | 8.7 Million USD | -12.12% |
| 1999 Q4 | 11.1 Million USD | 27.59% |
| 1999 FY | 29.9 Million USD | 100.67% |
| 1998 FY | 14.9 Million USD | 964.29% |
| 1998 Q4 | 6.6 Million USD | 24.53% |
| 1998 Q3 | 5.3 Million USD | 0.0% |
| 1998 Q2 | 5.3 Million USD | 1.92% |
| 1998 Q1 | 5.2 Million USD | 57.58% |
| 1997 Q1 | 300 Thousand USD | -25.0% |
| 1997 FY | 1.4 Million USD | 0.0% |
| 1997 Q4 | 3.3 Million USD | 200.0% |
| 1997 Q3 | 1.1 Million USD | 175.0% |
| 1997 Q2 | 400 Thousand USD | 33.33% |
| 1996 Q1 | 300 Thousand USD | -25.0% |
| 1996 Q2 | 500 Thousand USD | 66.67% |
| 1996 Q3 | 300 Thousand USD | -40.0% |
| 1996 Q4 | 400 Thousand USD | 33.33% |
| 1996 FY | 1.4 Million USD | 40.0% |
| 1995 Q4 | 400 Thousand USD | 100.0% |
| 1995 Q1 | 300 Thousand USD | 200.0% |
| 1995 FY | 1 Million USD | 150.0% |
| 1995 Q3 | 200 Thousand USD | -50.0% |
| 1995 Q2 | 400 Thousand USD | 33.33% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| 1994 FY | 400 Thousand USD | 300.0% |
| 1994 Q1 | 200 Thousand USD | 100.0% |
| 1994 Q2 | 100 Thousand USD | -50.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1993 FY | 100 Thousand USD | 0.0% |
| 1993 Q1 | 100 Thousand USD | 0.0% |
| 1993 Q4 | 100 Thousand USD | 0.0% |
| 1993 Q2 | - USD | -100.0% |
| 1993 Q3 | 100 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -9465.843% |
| BrainsWay Ltd. | 31.78 Million USD | -3529.212% |
| Cerus Corporation | 156.36 Million USD | -637.716% |
| Envoy Medical, Inc. | 316 Thousand USD | -364945.886% |
| electroCore, Inc. | 16.03 Million USD | -7096.163% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -179021.894% |
| IceCure Medical Ltd | 3.22 Million USD | -35624.528% |
| Inogen, Inc. | 315.66 Million USD | -265.439% |
| OrthoPediatrics Corp. | 148.73 Million USD | -675.586% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -47410.091% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -315940.592% |
| MaxCyte, Inc. | 41.28 Million USD | -2693.899% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -58982.195% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -1041494.431% |
| Orthofix Medical Inc. | 746.64 Million USD | -54.498% |
| PAVmed Inc | 2.45 Million USD | -46945.065% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -5022.541% |
| RxSight, Inc. | 89.07 Million USD | -1194.998% |
| Sight Sciences, Inc. | 81.05 Million USD | -1323.146% |
| SI-BONE, Inc. | 138.88 Million USD | -730.57% |
| TELA Bio, Inc. | 58.45 Million USD | -1873.457% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -516.48% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -8258.416% |
| Acutus Medical, Inc. | 7.16 Million USD | -16001.968% |
| Talis Biomedical Corporation | 412 Thousand USD | -279886.65% |
| Spectral AI, Inc. | 18.05 Million USD | -6288.707% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -11546.088% |
| CVRx, Inc. | 39.29 Million USD | -2835.602% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -118981.021% |
| Bioventus Inc. | 512.34 Million USD | -125.15% |
| Venus Concept Inc. | 76.35 Million USD | -1410.785% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -6131.673% |
| 908 Devices Inc. | 50.22 Million USD | -2196.572% |
| Alphatec Holdings, Inc. | 482.26 Million USD | -139.195% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -1497154.815% |
| NeuroPace, Inc. | 65.42 Million USD | -1663.264% |
| LENSAR, Inc. | 42.16 Million USD | -2635.853% |
| Apyx Medical Corporation | 52.34 Million USD | -2103.566% |
| Cutera, Inc. | 212.36 Million USD | -443.18% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -3358.076% |
| BioSig Technologies, Inc. | 18 Thousand USD | -6408483.333% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -592.146% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -4715.466% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 25.171% |
| Axonics, Inc. | 366.37 Million USD | -214.85% |
| Outset Medical, Inc. | 130.37 Million USD | -784.783% |
| IRIDEX Corporation | 51.86 Million USD | -2123.958% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -747.005% |
| IRadimed Corporation | 65.56 Million USD | -1659.464% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -97990.561% |
| INVO Bioscience, Inc. | 3.02 Million USD | -38089.583% |
| Telesis Bio, Inc. | 27.5 Million USD | -4093.337% |
| Viemed Healthcare, Inc. | 183 Million USD | -530.325% |
| Varex Imaging Corporation | 811 Million USD | -42.237% |
| Quipt Home Medical Corp. | 221.74 Million USD | -420.219% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -1579.716% |
| Dynatronics Corporation | 32.53 Million USD | -3445.664% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -13192.752% |
| Semler Scientific, Inc. | 68.18 Million USD | -1591.812% |
| InMode Ltd. | 492.04 Million USD | -134.437% |
| Bruker Corporation | 2.96 Billion USD | 61.088% |
| Cytosorbents Corporation | 36.34 Million USD | -3073.493% |
| DexCom, Inc. | 3.62 Billion USD | 68.154% |
| Align Technology, Inc. | 3.86 Billion USD | 70.133% |
| Viveve Medical, Inc. | 6.42 Million USD | -17851.214% |
| ZimVie Inc. | 457.43 Million USD | -152.178% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -497.645% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -1041494.431% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | -54.275% |
| Profound Medical Corp. | 7.33 Million USD | -15635.121% |
| Insulet Corporation | 1.69 Billion USD | 32.028% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -814.946% |
| iCAD, Inc. | 17.31 Million USD | -6560.96% |
| Nuwellis, Inc. | 8.86 Million USD | -12913.82% |
| Biotricity, Inc. | 12.06 Million USD | -9462.397% |
| iRhythm Technologies, Inc. | 492.68 Million USD | -134.136% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -18490.572% |
| PAVmed Inc. | 2.45 Million USD | -46945.065% |
| BIOLASE, Inc. | 49.16 Million USD | -2246.32% |
| Beyond Air, Inc. | 1.15 Million USD | -99429.336% |
| FONAR Corporation | 102.88 Million USD | -1021.208% |
| AxoGen, Inc. | 159.01 Million USD | -625.445% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -320.353% |
| Inari Medical, Inc. | 493.63 Million USD | -133.685% |
| UFP Technologies, Inc. | 400.07 Million USD | -188.334% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -6201754.839% |
| Tenon Medical, Inc. | 2.92 Million USD | -39297.029% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -16833.919% |
| AdaptHealth Corp. | 3.2 Billion USD | 63.954% |
| Sintx Technologies, Inc. | 2.62 Million USD | -43811.115% |
| NanoVibronix, Inc. | 2.28 Million USD | -50427.595% |
| Quanterix Corporation | 122.36 Million USD | -842.685% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -4626.675% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -475.274% |
| TransMedics Group, Inc. | 241.62 Million USD | -377.415% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -8226.44% |
| NeuroMetrix, Inc. | 5.9 Million USD | -19446.889% |
| Hyperfine, Inc. | 11.03 Million USD | -10356.354% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -598.479% |
| Biomerica, Inc. | 5.41 Million USD | -21202.77% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -2181.491% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -551.227% |